Hepatitis C: A 20-Year Debt Comes Due

American Journal of Managed Care

Volumn 10, Issue SUPPL. 2, 2004, Pages

  McHutchison, John G ^b   Bacon, Bruce R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

DRUG COST; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT;

DISEASE OUTBREAKS; HEPATITIS C; HUMANS; INCIDENCE; MANAGED CARE PROGRAMS; MASS SCREENING; UNITED STATES;

EID: 18744434714     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341: 556-562.
2. Centers for Disease Control and Prevention. Division of Viral Hepatitis. Disease burden from viral hepatitis A, B, and C in the United States. August 2002.
3. National institutes of Health. Consensus Development Conference Statement: Management of Hepatitis C: 2002-June 10-12, 2002. Hepatology. 2002;36:S3-S20.
4. National Institutes of Diabetes and Digestive and Kidney Disorders, National Institutes of Health. Chronic Hepatitis C: Current Disease Management. NIH Publication No. 03-4230, February 2003. www.digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/index.htm. Accessed November 14, 2003.
5. Williams I. Epidemiology of hepatitis C in the United States. Am J Med. 1999;107:2S-9S.
6. Reed C. Use guidelines to control hepatitis C costs. PBM News. 2003;8:3.